<DOC>
	<DOCNO>NCT00189436</DOCNO>
	<brief_summary>Subjects age 1-8 year discharge emergency department/outpatient care facility diagnosis asthma/bronchospasm/wheezing usual standard care enrol open-label , randomize , parallel-group study compare efficacy nebulized budesonide oral corticosteroid prevent asthma exacerbation relapse rate 21-day follow-up period .</brief_summary>
	<brief_title>Effect Nebulized Budesonide Oral Corticosteroids Wheezing Episode Relapse Children</brief_title>
	<detailed_description>Secondary outcome include urinary cortisol-creatinine ration , symptom severity score peak flow rate .</detailed_description>
	<mesh_term>Respiratory Sounds</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Children age 18 year old Discharge emergency department/outpatient clinic diagnosis asthma exacerbation usual standard care Subjects must able show efficient use jet nebulizer Subjects require hospitalization Subjects receive oral steroid 1 week prior presentation emergency department . Subjects FEV1 &lt; 50 % predicted Subjects comorbid medical condition ( renal cardiovascular disease ) Subjects report history HIV Subjects unable follow study visit Subjects frequently enuretic</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Asthma</keyword>
</DOC>